Initial Treatment for Suspected Bacterial or Fungal Skin Infection
For suspected bacterial skin infections in immunocompetent patients, initiate oral beta-lactam antibiotics (cephalexin 500mg three times daily or amoxicillin-clavulanate 500-875mg twice daily) for mild-to-moderate infections, while simple abscesses require only incision and drainage without antibiotics unless systemic signs are present. 1, 2
Bacterial Skin Infections
Mild-to-Moderate Infections (Cellulitis, Erysipela, Impetigo)
First-line oral therapy:
- Cephalexin 500mg three times daily for streptococcal and staphylococcal infections in areas where community-acquired MRSA (CA-MRSA) is not prevalent 1, 2, 3
- Amoxicillin-clavulanate 500-875mg twice daily provides adequate Gram-positive coverage 1
- Dicloxacillin or cefuroxime are alternative beta-lactam options 1
Duration: 7-14 days depending on clinical response 4, 1
MRSA Suspected or Confirmed
If CA-MRSA is prevalent in your area or suspected based on clinical features (purulent drainage, abscess formation, treatment failure):
- Avoid beta-lactams as they will be ineffective 1
- Consider clindamycin, trimethoprim-sulfamethoxazole, or doxycycline for outpatient oral therapy 4
- For severe infections requiring parenteral therapy: vancomycin, linezolid, or daptomycin 4, 1
Abscesses and Furuncles
Incision and drainage is the primary treatment without antibiotics for simple, uncomplicated abscesses 1
Add antibiotics only if:
- Systemic signs of infection present (fever, tachycardia, hypotension) 1
- Immunocompromised patient 1
- Incomplete source control 1
- Significant surrounding cellulitis 1
- Complex abscess (perianal, perirectal, injection drug use sites) requiring broad-spectrum coverage for Gram-positives, Gram-negatives, and anaerobes 1
Severe/Complicated Infections
Parenteral broad-spectrum therapy is required for:
- Systemic toxicity or hemodynamic instability 5
- Deep tissue involvement or necrotizing infections 1
- Immunocompromised hosts 4
Empiric regimens:
- Ampicillin-sulbactam 1.5-3g IV every 6-8 hours 4, 5
- Piperacillin-tazobactam 3.37g IV every 6-8 hours 4, 1
- Vancomycin plus piperacillin-tazobactam or a carbapenem for MRSA coverage with Gram-negative/anaerobic activity 1, 5
Bite Wounds (Animal or Human)
Prophylactic antibiotics are indicated given infection rates of 30-50% for cat bites, 5-25% for dog bites, and 20-25% for human bites 1
Preferred regimen:
- Amoxicillin-clavulanate 500-875mg twice daily orally 4, 1
- Ampicillin-sulbactam 1.5-3g IV every 6-8 hours for severe infections 4
- Covers Pasteurella multocida (animal bites), streptococci, staphylococci, and anaerobes 4
Duration: 7-10 days 4
Fungal Skin Infections
Superficial Dermatophyte Infections (Tinea Corporis, Cruris, Pedis)
Topical antifungals are first-line for localized infections 6, 7
Oral therapy is indicated when:
Oral regimens:
- Terbinafine 250mg daily for 1-2 weeks (tinea corporis/cruris) or 2 weeks (tinea pedis) 8
- Itraconazole 100mg daily for 2 weeks or 200mg daily for 7 days 8
- Fluconazole 150mg once weekly for 2-3 weeks 8
Pityriasis Versicolor (Malassezia furfur)
Oral options:
- Fluconazole 400mg single dose 8
- Itraconazole 200mg daily for 5-7 days 8
- Terbinafine is ineffective for this organism 8
Candidal Skin Infections
Topical nystatin or azoles for localized infections 6
Systemic therapy for immunocompromised patients:
- Fluconazole 100-400mg daily (note: Candida krusei and Candida glabrata are resistant) 4
- Echinocandin for severe infections or resistant species 4
- Duration: 2 weeks after resolution of skin lesions 4
Critical Pitfalls to Avoid
- Do not use beta-lactams empirically in areas with high CA-MRSA prevalence without considering MRSA-active alternatives 1
- Do not prescribe antibiotics for simple abscesses that can be adequately drained 1
- Do not use terbinafine for pityriasis versicolor—it is ineffective against Malassezia 8
- Do not delay surgical debridement in necrotizing infections; antibiotics alone are insufficient 1, 5
- Do not use high-pressure irrigation in wounds as this spreads bacteria into deeper tissue planes 1